Companies / Guardian Pharmacy Services, Inc.

Guardian Pharmacy Services, Inc.

NYSE: GRDNCIK 1802255ATLANTA, GA

Financials · FY2025

Revenue$1.45B
Net income$49.22M
Total debt$0
Cash$89.81M
Diluted EPS—
Shares outstanding63.3M

Ownership

63.3M shares outstanding · as of Aug 3, 2026
21.7%10%+ / strategic
Ownership
78.6%Class A
Share classes
Class A78.62%
Class B21.38%
10%+ / strategic21.66%13,721,882
Institutions26.86%17,012,780
Public float51.48%32,607,642

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 11

View all →
Insider% of sharesShares
Bindley Capital Partners I, LLC10% owner
16.69%10,569,491
Bindley William EFormerDirector · 10% owner
16.69%10,569,491
Salentine Thomas J JrFormerDirector · 10% owner
16.69%10,569,491
Ackerman JohnFormerDirector
5.16%3,266,047
Pharmacy Investors, LLC—
3.87%2,449,867
Burke FredFormerSee Remarks · Director
3.38%2,139,239
Forbes KendallFormerSee Remarks
1.68%1,061,826
Morris David KFormerSee Remarks · Director
1.42%896,341
Cardinal Equity Fund, L.P.—
1.29%816,180
Cosler Steven DFormerDirector
0.05%29,012

Institutional holders 146

View all →
HolderValue% of shares
BlackRock, Inc.$65.99M2.49%
Brown Advisory Inc$47.42M1.99%
Vanguard Group Inc$40.73M2.14%
TimesSquare Capital Management, LLC$39.85M1.50%
Boston Partners$38.40M1.61%
Valiant Capital Management, L.P.$37.08M1.95%
Wellington Management Group LLP$33.80M1.77%
Woodline Partners LP$31.71M1.66%
Franklin Resources, Inc.$29.83M1.57%
State Street Corporation$24.71M0.93%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 20, 2026Salentine Thomas J Jr
Director
SellClass A Common Stock$105.99M-3.6M
-44.41%
4,469,316
7.06% of shares
high
Mar 20, 2026Bindley Capital Partners I, LLC
10% owner
SellClass A Common Stock$105.99M-3.6M
-44.41%
4,469,316
7.06% of shares
high
Mar 20, 2026Bindley William E
Director
SellClass A Common Stock$105.99M-3.6M
-44.41%
4,469,316
7.06% of shares
high
Mar 20, 2026Pharmacy Investors, LLCSellClass A Common Stock$24.57M-828K
-44.41%
1,035,928
1.64% of shares
high
Mar 20, 2026Ackerman John
Director
SellClass A Common Stock$24.57M-828K
-44.41%
1,035,928
1.64% of shares
high
Mar 20, 2026Burke Fred
Executive
SellClass A Common Stock$19.93M-671K
-44.41%
840,413
1.33% of shares
high
Mar 20, 2026Forbes Kendall
Executive
SellClass A Common Stock$10.29M-347K
-43.34%
453,256
0.72% of shares
medium
Mar 20, 2026Ackerman John
Director
SellClass A Common Stock$8.18M-276K
-44.41%
345,123
0.54% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Brown Advisory IncPassive13G/A—1,644,569—
BlackRock, Inc.Passive13G/A—1,507,822—
Wellington Management Group LLPPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
GRDNCommon StockEquity40145W101BBG01JM69P40